Michael Tachezy Selected Research

Pancreatic Neoplasms (Pancreatic Cancer)

8/2023	Failure of a Multi-Centric Clinical Trial Investigating Neoadjuvant Radio-Chemotherapy in Resectable Pancreatic Carcinoma (NEOPA-NCT01900327)-Which Lessons Are Learnt?
1/2018	Improved Risk Stratification by Circulating Tumor Cell Counts in Pancreatic Cancer.
1/2017	Detection of mutant KRAS and TP53 DNA in circulating exosomes from healthy individuals and patients with pancreatic cancer.
12/2014	ABO blood group IgM isoagglutinins interact with tumor-associated O-glycan structures in pancreatic cancer.
9/2014	Serum EpCAM expression in pancreatic cancer.
1/2014	Carcinoembryonic antigen-related cell adhesion molecules (CEACAM) 1, 5 and 6 as biomarkers in pancreatic cancer.
1/2012	ALCAM (CD166) expression and serum levels in pancreatic cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael Tachezy Research Topics

Disease

23	Neoplasms (Cancer) 10/2023 - 05/2011
9	Adenocarcinoma 02/2022 - 08/2011
8	Neoplasm Metastasis (Metastasis) 10/2023 - 10/2011
7	Pancreatic Neoplasms (Pancreatic Cancer) 08/2023 - 01/2012
4	Colorectal Neoplasms (Colorectal Cancer) 04/2024 - 09/2012
4	Carcinoma (Carcinomatosis) 02/2024 - 09/2013
4	Carcinogenesis 12/2022 - 08/2011
4	Anastomotic Leak 08/2022 - 01/2020
4	Esophageal Neoplasms (Esophageal Cancer) 10/2021 - 07/2012
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2019 - 01/2012
2	Pleural Empyema (Pyothorax) 02/2023 - 01/2023
2	Chronic Pancreatitis 01/2017 - 01/2012
2	Neoplasms, Cystic, Mucinous, and Serous 01/2017 - 10/2010
2	Atherosclerosis 03/2008 - 07/2007
1	Wounds and Injuries (Trauma) 02/2024
1	Surgical Wound Infection 02/2024
1	Incisional Hernia 10/2023
1	Colonic Neoplasms (Colon Cancer) 10/2023
1	Infections 02/2023
1	Empyema 01/2023
1	Hepatocellular Carcinoma (Hepatoma) 12/2022
1	Pathologic Constriction (Stenosis) 08/2022
1	Intestinal Fistula 01/2022
1	Sepsis (Septicemia) 01/2020
1	Neuroblastoma 08/2016
1	Inflammation (Inflammations) 01/2016
1	Stomach Neoplasms (Stomach Cancer) 01/2016
1	Squamous Cell Carcinoma of Head and Neck 10/2014
1	Lung Diseases (Lung Disease) 01/2012
1	Breast Neoplasms (Breast Cancer) 01/2012
1	Prostatic Neoplasms (Prostate Cancer) 12/2011

Drug/Important Bio-Agent (IBA)

9	Activated-Leukocyte Cell Adhesion Molecule (Neurolin)IBA 08/2016 - 10/2011
7	Proteins (Proteins, Gene)FDA Link 08/2023 - 12/2011
5	Biomarkers (Surrogate Marker)IBA 08/2023 - 10/2011
4	Interleukin-22 (IL-22)IBA 10/2023 - 12/2022
3	Cell Adhesion MoleculesIBA 09/2019 - 01/2014
2	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 04/2024 - 08/2023
2	Carrier Proteins (Binding Protein)IBA 01/2023 - 12/2022
2	Immunoglobulins (Immunoglobulin)IBA 08/2016 - 12/2011
2	Chemokine ReceptorsIBA 09/2013 - 08/2011
1	polihexanideIBA 02/2024
1	SolutionsIBA 02/2024
1	CD13 Antigens (Alanine Aminopeptidase)IBA 10/2023
1	InterleukinsIBA 10/2023
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 08/2023
1	Calcibiotic Root Canal SealerIBA 08/2023
1	Neutralizing AntibodiesIBA 01/2023
1	CytokinesIBA 01/2023
1	MetalsIBA 08/2022
1	Indicators and Reagents (Reagents)IBA 04/2022
1	1-Acylglycerophosphocholine O-Acyltransferase (1 Acylglycerophosphocholine O Acyltransferase)IBA 10/2021
1	Integrin alphaVIBA 06/2021
1	SelectinsIBA 06/2021
1	Neural Cell Adhesion Molecules (Neural Cell Adhesion Molecule)IBA 03/2020
1	Interleukin-17 (Interleukin 17)IBA 01/2020
1	Interleukin-10 (Interleukin 10)IBA 01/2020
1	DNA (Deoxyribonucleic Acid)IBA 01/2017
1	Fluorouracil (Carac)FDA LinkGeneric 09/2016
1	130-nm albumin-bound paclitaxelIBA 09/2016
1	folfirinoxIBA 09/2016
1	Gemcitabine FDA Link 09/2016
1	Irinotecan (Camptosar)FDA LinkGeneric 09/2016
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 09/2016
1	Leucovorin (Folinic Acid)FDA Link 09/2016
1	Tumor Biomarkers (Tumor Markers)IBA 04/2016
1	TenascinIBA 04/2016
1	AlbuminsIBA 01/2016
1	C-Reactive ProteinIBA 01/2016
1	ABO Blood-Group SystemIBA 12/2014
1	Glycoproteins (Glycoprotein)IBA 12/2014
1	Polysaccharides (Glycans)IBA 12/2014
1	Immunoglobulin M (IgM)IBA 12/2014
1	Blood Group Antigens (Blood Groups)IBA 12/2014
1	GlycoconjugatesIBA 12/2014
1	Epithelial Cell Adhesion MoleculeIBA 09/2014
1	Carcinoembryonic AntigenIBA 01/2014
1	Chemokine CXCL12IBA 09/2013
1	CXCR4 Receptors (CXCR4 Receptor)IBA 09/2013
1	Messenger RNA (mRNA)IBA 01/2012
1	Complementary DNA (cDNA)IBA 01/2012
1	MicroRNAs (MicroRNA)IBA 01/2012
1	Prostate-Specific Antigen (Semenogelase)IBA 12/2011

Therapy/Procedure

13	Therapeutics 02/2023 - 05/2011
4	Esophagectomy 02/2024 - 06/2021
2	Drug Therapy (Chemotherapy) 08/2023 - 09/2016
2	Stents 08/2022 - 06/2021
2	Neoadjuvant Therapy 02/2022 - 06/2014
1	Laparotomy 02/2024
1	Operative Surgical Procedures 02/2024
1	Herniorrhaphy 10/2023
1	Chemoradiotherapy 08/2023
1	Length of Stay 01/2023
1	Debridement 01/2023
1	Endoscopes 01/2023
1	Duration of Therapy 08/2022
1	Critical Care (Surgical Intensive Care) 08/2022
1	Aftercare (After-Treatment) 06/2021
1	Catheters 01/2020
1	Lymph Node Excision (Lymph Node Dissection) 01/2016
1	Metastasectomy 01/2016